Across Asia, government health and safety authorities have tightened regulations on medical devices this year, as markets continue to experience rapid change, and as the devices themselves gain sophistication and complexity at a blistering pace.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Recent healthcare and political changes are opening the door for medical device companies.
The country can’t ignore the fact that Asia is the future of medtech growth.
Foreign device companies can expect a big opportunity for expansion in Southeast Asia.
As the incidence of diabetes across Asia expands, demand for medical devices and drugs to treat the disease is intensifying.
With prices jumping in China, Western device manufacturers and suppliers are looking elsewhere.